| Literature DB >> 28218689 |
Gizem Ertürk1, Bo Mattiasson2,3.
Abstract
Capacitive biosensors belong to the group of affinity biosensors that operate by registering direct binding between the sensor surface and the target molecule. This type of biosensors measures the changes in dielectric properties and/or thickness of the dielectric layer at the electrolyte/electrode interface. Capacitive biosensors have so far been successfully used for detection of proteins, nucleotides, heavy metals, saccharides, small organic molecules and microbial cells. In recent years, the microcontact imprinting method has been used to create very sensitive and selective biorecognition cavities on surfaces of capacitive electrodes. This chapter summarizes the principle and different applications of capacitive biosensors with an emphasis on microcontact imprinting method with its recent capacitive biosensor applications.Entities:
Keywords: affinity biosensors; capacitive biosensors; microcontact imprinting
Mesh:
Year: 2017 PMID: 28218689 PMCID: PMC5336051 DOI: 10.3390/s17020390
Source DB: PubMed Journal: Sensors (Basel) ISSN: 1424-8220 Impact factor: 3.576
Figure 1(A) Schematic diagram showing the change in capacitance (ΔC) as a function of time when the analyte (IgG) interacts with the receptor molecule (Protein A) immobilized on the surface of the electrode. Subsequent rise in signal is due to the dissociation after the injection of the regeneration solution. In an ideal sensorgram, the baseline should turn back to the original level after regeneration of the surface; (B) Immobilization of the receptor molecule on the transducer surface via a self-assembled monolayer (SAM) of alkylthiols. When the target molecule interacts with the receptor, this creates a double layer of counter ions around the gold transducer which results in a change in the capacitance. (Reproduced from Reference [8] with permission).
Different applications of capacitive biosensors developed for different targets.
| Target | Sensor Preparation Method | Dynamic range (M) | Limit of Detection (M) | Selectivity | Stability | Ref. | |
|---|---|---|---|---|---|---|---|
| Proteins | Cholera toxin (CT) | Immobilization of anti-CT antibodies on self-assembled monolayer (SAM) of lipoic acid and 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) | 1.0 × 10−13 –1.0 × 10−10 | 1.0 × 10−14uiu | N/D | N/D | [ |
| Cholera toxin (CT) | Immobilization of anti-CT on gold nanoparticles incorporated on a poly-tyramine layer | 0.1 × 10−18–10 × 10−12 | 9.0 × 10−20 | N/D | Up to 36 times with an RSD of 2.5% | [ | |
| HIV-1 p24 antigen | Immobilization of anti-HIV 1 p24 antigen on gold nanoparticles incorporated on a poly-tyramine layer | 10.1 × 10−20–10.1 × 10−17 | 3.32 × 10−20 | N/D | N/D | [ | |
| VEGF | Immobilization of anti-VEGF aptamer first capturing the VEGF protein then, sandwiching with antibody-conjugated magnetic beads | 13 × 10−14–2.6 × 10−11 | N/D | N/D | N/D | [ | |
| Nucleic acids | 25-mer oligo C | Covalent attachment of 25-mer oligo C on poly-tyramine modified electrode | 10−8–10−11 | 10−11 | Oligo-T was used as the competing agent, when the temperature was increased from RT to 50 °C, the ΔC value decreased from 48 nF·cm−2 to 3 nF·cm−2 | N/D | [ |
| ssDNA | Thiol modified oligonucleotides were immobilized on Au and 3-glycidoxypropyl-tri-methoxy silane (GOPTS) | 0.5 × 10−6–1.0 × 10−3 | N/D | N/D | GOPTS functionalized surfaces were more stable at 4 °C. Ten-fold decrease in fluorescence intensity after 1 week even when the substrates were stored at 4 °C. | [ | |
| Nampt | Immobilization of ssDNA aptamers on SAM of mercaptopropionic acid (MPA) | 0–45 × 10−10 | 1.8 × 10−11 | N/D | N/D | [ | |
| Target DNA | Immobilization of pyrrolidinyl peptide nucleic acid probes (acpcPNA) | 1.0 × 10−11–1.0 × 10−10 | 6–10 × 10−12 | Complementary DNA provided a much higher ΔC compared to single and double mismatched DNA | Could be reused for 58–73 times with an average residual activity of ≥98% | [ | |
| Cells | Total bacteria | Based on the interaction between | 12 CFU·mL−1–1.2 × 10−6 CFU·mL−1 | 12 CFU·mL−1 | N/D | For the first 35 cycles, the residual activity was 95% ± 3% (RSD = 3.2%). After 35 cycles, it was 85%. | [ |
| 8 × 105 CFU·mL−1–8 × 107 CFU·mL−1 | N/D | N/D | N/D | [ | |||
| Heavy metals | Hg(II), Cu(II), Zn(II), Cd(II) | Immobilization of metal resistance and metal regulatory proteins on gold electrode | 10−15–10−3 | N/D | N/D | N/D | [ |
| Cu(II), Cd(II), Hg(II) | 1. Immobilization of whole bacterial cell to emit a bioluminescent/fluorescent signal in the presence of heavy metal ions | 0–200 × 10−6 | 1.0 × 10−6 | N/D | 84% of the activity loss within 6 days | [ | |
| 2. Immobilization of heavy metal binding proteins | 10−15–10−1 | Stable over 16 days | |||||
| Saccharides | Glucose | Immobilization of ConA on gold nanoparticles incorporated on the tyramine modified gold electrode | 1.0 × 10−6–1.0 × 10−2 | 1.0 × 10−6 | Small sugars including D-fructose, D-mannose, D-maltose, methyl-α-D-glucopyranoside, methyl-α-D-mannopyranoside also bound instead of glucose | A neglectable loss in sensitivity after 10 cycles (7.5%) | [ |
| Glucose | Immobilization of ConA and replacement of small glucose with the large glucose polymer | 1.0 × 10−5–1.0 × 10−1 | 1.0 × 10−6 | Small molecules and high molecular weight dextran also bound instead of glucose | N/D | [ | |
| Small molecules | Metergoline | Immobilization of molecularly imprinted spherical beads on modified gold electrode | 1–50 × 10−6 | 1.0 × 10−6 | Cross reactant contribution was maximum 1.3 nF | N/D | [ |
| Aflatoxin B1 | Bioimprinting | 3.2 × 10−6–3.2 × 10−9 | 6.0 × 10−12 | Competing agents’ binding was significantly lower than aflatoxin B1 | Little variation over 28 injections with non-reduced Schiff’s bases | [ | |
| Ochratoxin A (OTA) | Monoclonal anti-OTA immobilization on Si3N4 substrate combined with magnetic nanoparticles (MNPs) | 2.47–49.52 × 10−12 | 4.57 × 10−12 | Differences for ochratoxin B and aflatoxin B1 were not significant | N/D | [ |
Figure 2Schematic representation of the competitive glucose binding assay. (a) When glucose is injected into the capacitive system, it binds to the immobilized Concanavalin A (ConA) on the surface. However, this binding does not make any change in the capacitance level, as shown in the graph on the right, due to the small size of the glucose molecule; (b) When a glucose polymer (dextran) is injected into the system, binding of this big polymer to ConA results in a decrease in the capacitance signal; (c) When glucose is injected into the system again, displacement of dextran with glucose results in the capacitance turn back to the original baseline level. (Reproduced from Reference [22] with permission).
Molecularly imprinted polymers (MIPs) produced with high binding efficiency for affinity chromatography applications.
| Template | Method | Matrix | Comments | Ref. |
|---|---|---|---|---|
| Benzo[a]pyrene (BAP) | BAP-imprinted poly (2-hydroxyethylmethacrylate-N-methacryloyl-(L)-phenylalanine composite cryogel cartridge | Aqueous solutions | Preconcentration on BAP with HPLC equipped with a fluorescence detector (HPLC-FLD) | [ |
| Melamine | Melamine imprinted monolithic cartridges | Water + milk | MIP-solid phase extraction Extraction and enrichment of melamine | [ |
| Cholesterol | Cholesterol imprinted polymeric nanospheres | Gastrointestinal mimicking solution | Cholesterol adsorption | [ |
| Catalase | Iron chelated poly (2-hydroxyethylmethacrylate-N-methacryloyl-(L)-glutamic acid cryogel discs | Rat liver | Catalase purification from rat liver | [ |
| L-phenylalanine (L-Phe) | L-Phe imprinted cryogel cartridges | Aqueous solutions | Chiral separation of l-phenylalanine with FPLC (fast protein liquid chromatography) | [ |
| Triazine | Triazine imprinted monolithic columns | Aqueous solutions | Separation of triazine with capillary electro-chromatography (CEC) | [ |
| Cytochrome c | Surface imprinted bacterial cellulose nanofibers | Rat liver | Cytochrome c purification from rat liver | [ |
Figure 3Scanning electron microscope (SEM) pictures of the electrode surface after functionalization with imprinted polymers. From left to right, top to bottom: (a) SEM picture of electrode surface; (b,c) SEM pictures of centre of the electrode; and (d) SEM picture of the border between the gold layer and wafer. (Reproduced from Reference [23] with permission).
Figure 4Schematic representation of bio-imprinting process. (Reproduced from Reference [24] with permission).
Figure 5Different applications of MIPs in: (A) immunosensors; (B) enzyme-linked immunosorbent assay (ELISA); (C) enzyme electrodes, reaction rate and analyte concentration of enzyme electrodes and catalytic MIP-coated electrodes can be estimated by electroactive substrate/product consumption/production during the catalytic reaction or electron transfer from the electrode surface to the active centre of enzyme/MIP; (D) DNA chips; and (E) enzyme immobilization and competitive binding of the analyte. (Reproduced from Reference [52] with permission).
Capacitive biosensors developed for different targets using microcontact imprinting method.
| Target | Biosensing Method | Monomers | Dynamic Range | LOD | Selectivity | Stability | Ref. |
|---|---|---|---|---|---|---|---|
| Bovine Serum Albumin (BSA) | Capacitive biosensor with current pulse method | Methacrylic acid (MAA); Poly ethyleneglycol-dimethacrylate (PEGDMA) | 1.0 × 10−20 M–1.0 × 10−8 M | 1.0 × 10−19 M | For human serum albumin (HSA): 5%; For IgG: 3% | >70 assays during 2 months | [ |
| Prostate specific antigen (PSA) | Capacitive biosensor with current pulse method | MAA; EGDMA | 2.0 × 10−17 M–2.0 × 10−10 M | 16 × 10−17 M | Selectivity coefficient (k) = 2.27 for HSA, k = 2.02 for IgG | About same level during 50 injections | [ |
| Capacitive biosensor with current pulse method | HEMA; (2-Hydroxyethyl methacrylate), N-methacryloyl-L-histidine methyl ester (MAH), EGDMA | 1.0 × 102–1.0 × 107 CFU·mL−1 | 70 CFU·mL−1 | K = 3.14 for | About same level during 70 injections | [ | |
| Trypsin | Capacitive biosensor with current pulse method | N-isopropylacrylamide (NIPAm), N,N-methylenebisacryl, amide (MBAAm), Acrylamide, Hydroxymethylacrylamide | 1.0 × 10−13 M–1.0 × 10−7 M | 3.0 × 10−13 M | K = 733.1 for chymotrypsin (chy), k = 10.56 for BSA, k = 6.50 for lysozyme (Lyz), k = 3.46 for cytochrome c (cyt c) | The loss in performance was about 2% after 80 analyses | [ |
Figure 6(a) Schematic representation of the capacitive system with current pulse method. The system is comprised of: (1) current source; (2) flow cell which is connected to the working, reference and auxiliary electrodes; (3) potential differential amplifier; and (4) a processor and ADC where the analogue potential is converted to digital signal; (b) A schematic view of Howland current pump used for supplying constant current; (c) Constant current supply to the sensor during the determined time periods to measure the resistance and capacitance; (d) Capacitance is measured every minute and each minute (pulse) contains five sub pulse measurements with 20 ms intervals. (Reproduced from reference [57] with permission).
Figure 7Schematic representation of automated flow injection capacitive system. The components shown in the figure are integrated into a box to make a single, portable unit. (Reproduced from Reference [63] with permission).
Figure 8Schematic representation of preparation of trypsin imprinted capacitive electrodes using microcontact imprinting procedure: (A) preparation of glass cover slips (protein stamps); (B) preparation of capacitive gold electrodes; and (C) imprinting of trypsin to the electrode surface via microcontact imprinting method. (Reproduced from Reference [60] with permission).